Morgan Stanley Sticks With Overweight on Zoetis, Sets $160 Target After Q4 Results
Morgan Stanley has maintained an Overweight rating and a $160.00 price target on Zoetis Inc., after the company reported quarterly results that included an earnings-per-share beat and provided operational guidance for 2026. The firm flagged investor attention on the trajectory of Zoetis' US Companion Animal segment amid intensifying competition, wh…